This project is aiming to identify the diagnostic utility of an ECG derived measurement by a Medical device (Vectraplex by VectraCor ltd) in patients who are undergoing cardiac investigations. This technology is based on the principle of vector ECG and an analysing system that computes a composite score termed a Cardiac Electrical Biomarker (CEB TM).~CEB has been validated in the detection of STEMI with high sensitivity and specificity in the detection ECG changes characteristic to STEMI. The CEB may be a more accurate way of identifying heart injury and causes of chest pain compared to standard tests, which could lead to faster diagnosis and treatment of these patients.~The diagnostic utility of the CEBTM in the following:~Acute chest pain assessment in the A&E department.~Acute chest pain assessment in the Primary Care Surgery.~Performance of CEB during inducible ischaemia in patients with stable angina~Performance of CEB during acute ischaemia in patients undergoing percutaneous coronary intervention (PCI)~Performance of CEB in patients undergoing cardio-toxic treatment
This project is aiming to identify the diagnostic utility CEB (Cardiac Electrical Biomarker) in patients who are undergoing cardiac investigations.